FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
SAN DIEGO, Jan. 30, 2018 -- (Healthcare Sales & Marketing Network) -- Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics announces that the U.S. Food and Drug Administration (FD... Biopharmaceuticals, FDA Dauntless Pharmaceuticals, acromegaly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2018 Category: Pharmaceuticals Source Type: news
Premenopausal women have poorer outcomes after adenomectomy
According to a study, published in theJournal of Clinical Endocrinology& Metabolism, premenopausal women with acromegaly have worse outcomes after transsphenoidal adenomectomy.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 8, 2018 Category: Endocrinology Source Type: news
Acromegaly patients in remission still at increased risk of diabetes
According to a French study, published in theJournal of the Endocrine Society,even acromegaly patients in remission have an increased risk of developing diabetes and related metabolic disorders.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 5, 2017 Category: Endocrinology Source Type: news
EndoBreak: T1D and Vitamin D; VA's T2D Guideline; Oral Acromegaly Drug
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 27, 2017 Category: Cardiology Source Type: news
World ’s tallest 12-year-old towers above at 7ft 5ins
Gabriel Gomes, from Brazil, suffers from gigantism, caused by a tumour of the pituitary gland. A documentary called Body Bizarre, airing on Thursday, follows the boy's journey. (Source: the Mail online | Health)
Source: the Mail online | Health - October 17, 2017 Category: Consumer Health News Source Type: news
Chiasma begins enrolment in Phase III trial for acromegaly
Chiasma has started patient enrolment in Phase III CHIASMA OPTIMAL clinical trial of its product candidate Mycapssa (octreotide capsules) as a maintenance therapy to treat adults with acromegaly. (Source: Drug Development Technology)
Source: Drug Development Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news
Midatech files CTA for MTD201 ’s carcinoid cancer and acromegaly trial
UK-based specialist pharmaceutical firm Midatech Pharma has submitted a clinical trial application (CTA) for its drug candidate MTD201 to treat carcinoid cancer and acromegaly. (Source: Drug Development Technology)
Source: Drug Development Technology - September 4, 2017 Category: Pharmaceuticals Source Type: news
Chiasma and FDA agree on new Phase III trial design for acromegaly drug
The US Food and Drug Administration (FDA) has agreed on biopharmaceutical firm Chiasma ’s new Phase III clinical trial (OPTIMAL) design to evaluate its octreotide capsules product candidate Mycapssa as a maintenance therapy to treat adults with acrome… (Source: Drug Development Technology)
Source: Drug Development Technology - August 13, 2017 Category: Pharmaceuticals Source Type: news
Kent hairdresser with acromegaly could not stop growing
Lauren Bates, 26, from New Romney, Kent, was diagnosed with acromegaly. The rare condition was made famous by Richard Kiel, who played Jaws in The Spy Who Loved Me. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2017 Category: Consumer Health News Source Type: news
Kent hairdresser reveals her feet wouldn't stop growing
Lauren Bates, 26, from New Romney, Kent, was diagnosed with acromegaly. The rare condition was made famous by Richard Kiel, who played Jaws in The Spy Who Loved Me. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2017 Category: Consumer Health News Source Type: news
Celebrating 10 years of success for Infusion
As the business took off, more space was needed, and the company moved in 2009 to “real” office space just up the road in Haddam, CT, across the street from the Connecticut River, eventually employing a staff of 10 that year. A year later, in 2010, Infusion had doubled in size and became part of the UDG/Ashfield family.
Infusion continued to grow at a steady pace into new therapeutic areas with more clients and employees, and in October 2016, Infusion left its country setting and moved into larger corporate offices in downtown Middletown, CT.
Our staff now comprises 45 people and includes account executives, medical wr...
Source: Ashfield Healthcare News - July 11, 2017 Category: Pharmaceuticals Authors: Sarah Edwards Tags: Ashfield Source Type: news
Ipsen wins approval for gastroenteropancreatic neuroendocrine tumor drug
Ipsen (EPA:IPN) said today that Teijin Pharma Ltd. won approval from the Japanese Ministry of Health, Labor and Welfare for Ipsen’s Somatuline as a therapy for gastroenteropancreatic neuroendocrine tumors.
The subcutaneous drug was approved in Japan in 2012 for the treatment of acromegaly and pituitary gigantism.
Get the full story at our sister site, Drug Delivery Business News.
The post Ipsen wins approval for gastroenteropancreatic neuroendocrine tumor drug appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Pharmaceuticals Regulatory/Compliance Wall Street Beat Ipsen Teijin Pharma Source Type: news
Impaired QoL in Patients With Treated Acromegaly Impaired QoL in Patients With Treated Acromegaly
Find out which factors may negatively impact quality of life among patients with treated and controlled acromegaly.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 30, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Karachi father unable to get a job due to his giant hands
Ashraf-ud-din, 70, from Karachi, has suffered with the rare macrodactyly all of his life - a congenital form of gigantism. It has left him unable to get a job and has stopped him from gaining any skills. (Source: the Mail online | Health)
Source: the Mail online | Health - May 31, 2017 Category: Consumer Health News Source Type: news
Radiation Tx for Persistent Acromegaly Safe, Effective
(MedPage Today) -- Helped normalize IGF-1 levels after surgery failed (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 4, 2017 Category: Surgery Source Type: news
